Advise patients to discontinue XIGDUO XR immediately and to promptly notify their healthcare provider if unexplained hyperventilation, myalgia, malaise, unusual somnolence, dizziness, slow or irregular heartbeat, sensation of feeling cold (especially in the extremities), or other nonspecific symptoms occur
In this study, the brand name was extracted from the discontinuation note and used to determine if the drug was an AOM or ADM
This could include meeting clinical eligibility criteria, trying lower-cost or alternative interventions before coverage is approved, or requiring prior authorization
Accordingly, hyperfiltration decreases according to tubular glomerular feedback due to increased Na in the distal tubule
The study was observational, so it can only show associations, not whether the drugs caused the conditions
For oral semaglutide (Rybelsus) : If you miss a dose, skip it and take your next dose the following day